Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Double-blind, Randomized, Multicenter, Clinical Phase III Study to Evaluate the Efficacy and Safety of HX575 for the Treatment of Chemotherapy Associated Anemia in Cancer Patients

NCT00711958 is registered in ClinicalTrials.gov with Sandoz as lead sponsor.

NCT NCT00711958
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00711958 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Double-blind, Randomized, Multicenter, Clinical Phase III Study to Evaluate the Efficacy and Safety of HX575 for the Treatment of Chemotherapy Associated Anemia in Cancer Patients
Lead sponsor
Sandoz
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
December 31, 2005
Enrollment
114 (actual)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

anemia